---
title: "InventisBio (688382.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688382.SH/norm.md"
symbol: "688382.SH"
name: "InventisBio"
parent: "https://longbridge.com/en/quote/688382.SH.md"
datetime: "2026-03-13T22:23:50.855Z"
locales:
  - [en](https://longbridge.com/en/quote/688382.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688382.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688382.SH/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688382.SH/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688382.SH/norm.md)


# InventisBio (688382.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2468 | -0.1003 | -0.1101 | -0.1000 | 0.1127 |
| ROE | -32.53% | -14.65% | -14.20% | -12.85% | 14.69% |
| Revenue | 6.43M | 11.73M | 10.97M | 8.19M | 149.63M |
| Net income | -135.45M | -61.95M | -61.93M | -57.50M | 65.10M |
| Operating income | -104.46M | -74.74M | -72.88M | -64.50M | 50.60M |
| Gross margin | 163.29% | 86.50% | 87.87% | 85.89% | 102.08% |
| Net margin | -2105.98% | -528.17% | -564.32% | -702.15% | 43.51% |
| Profit quality | - | - | - | - | 106.24% |

## Balance Sheet (CNY)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | - | 1.76B | 1.81B | 1.87B | 1.92B |
| Leverage | - | 1.06 | 1.06 | 1.06 | 1.06 |
| BVPS | 2.88 | 2.88 | 2.97 | 3.06 | 3.14 |
| Turnover | - | 0.0988 | 0.0914 | 0.0853 | 0.0827 |
| Cash & STI | 1.53B | 1.53B | 1.58B | 1.63B | 1.69B |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | 30.41M | 34.31M | 42.61M | 44.82M |
| Net debt | -1.51B | -1.51B | -1.56B | -1.61B | -1.66B |

## Cash Flow Statement (CNY)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -52.81M | -45.22M | -62.02M | 47.63M |
| Investing CF | - | 210.99M | -33.73M | -259.63M | 127.63M |
| Financing CF | - | -2.06M | -2.36M | 5.55M | -4.01M |
| Free CF | - | -72.45M | -15.12M | -56.32M | 75.20M |
| OCF coverage | - | 2079.17% | -736.13% | -2322.61% | 951.67% |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | -1.16M | -2.45M | -2.67M | -5.00M |